dbSNP Short Genetic Variations
Welcome to the Reference SNP (rs) Report
All alleles are reported in the Forward orientation. Click on the Variant Details tab for details on Genomic Placement, Gene, and Amino Acid changes. HGVS names are in the HGVS tab.
Reference SNP (rs) Report
This page reports data for a single dbSNP Reference SNP variation (RefSNP or rs) from the new redesigned dbSNP build.
Top of the page reports a concise summary for the rs, with more specific details included in the corresponding tabs below.
All alleles are reported in the Forward orientation. Use the Genomic View to inspect the nucleotides flanking the variant, and its neighbors.
For more information see Help documentation.
rs121913377
Current Build 157
Released September 3, 2024
- Organism
- Homo sapiens
- Position
-
chr7:140753335-140753336 (GRCh38.p14) Help
The anchor position for this RefSNP. Includes all nucleotides potentially affected by this change, thus it can differ from HGVS, which is right-shifted. See here for details.
- Alleles
- CA>AT / CA>GT / CA>TT
- Variation Type
- MNV Multiple Nucleotide Variation
- Frequency
-
None
- Clinical Significance
- Reported in ClinVar
- Gene : Consequence
- BRAF : Missense Variant
- Publications
- 19 citations
- Genomic View
- See rs on genome
Frequency tab displays a table of the reference and alternate allele frequencies reported by various studies and populations. Table lines, where Population="Global" refer to the entire study population, whereas lines, where Group="Sub", refer to a study-specific population subgroupings (i.e. AFR, CAU, etc.), if available. Frequency for the alternate allele (Alt Allele) is a ratio of samples observed-to-total, where the numerator (observed samples) is the number of chromosomes in the study with the minor allele present (found in "Sample size", where Group="Sub"), and the denominator (total samples) is the total number of all chromosomes in the study for the variant (found in "Sample size", where Group="Study-wide" and Population="Global").
Variant Details tab shows known variant placements on genomic sequences: chromosomes (NC_), RefSeqGene, pseudogenes or genomic regions (NG_), and in a separate table: on transcripts (NM_) and protein sequences (NP_). The corresponding transcript and protein locations are listed in adjacent lines, along with molecular consequences from Sequence Ontology. When no protein placement is available, only the transcript is listed. Column "Codon[Amino acid]" shows the actual base change in the format of "Reference > Alternate" allele, including the nucleotide codon change in transcripts, and the amino acid change in proteins, respectively, allowing for known ribosomal slippage sites. To view nucleotides adjacent to the variant use the Genomic View at the bottom of the page - zoom into the sequence until the nucleotides around the variant become visible.
Sequence name | Change |
---|---|
GRCh38.p14 chr 7 | NC_000007.14:g.140753335_140753336delinsAT |
GRCh38.p14 chr 7 | NC_000007.14:g.140753335_140753336delinsGT |
GRCh38.p14 chr 7 | NC_000007.14:g.140753335_140753336delinsTT |
GRCh37.p13 chr 7 | NC_000007.13:g.140453135_140453136delinsAT |
GRCh37.p13 chr 7 | NC_000007.13:g.140453135_140453136delinsGT |
GRCh37.p13 chr 7 | NC_000007.13:g.140453135_140453136delinsTT |
BRAF RefSeqGene (LRG_299) | NG_007873.3:g.176429_176430delinsAT |
BRAF RefSeqGene (LRG_299) | NG_007873.3:g.176429_176430delinsAC |
BRAF RefSeqGene (LRG_299) | NG_007873.3:g.176429_176430delinsAA |
Molecule type | Change | Amino acid[Codon] | SO Term |
---|---|---|---|
BRAF transcript variant 1 |
NM_004333.6:c.1799_1800de… NM_004333.6:c.1799_1800delinsAT |
V [GTG] > D [GAT] | Coding Sequence Variant |
serine/threonine-protein kinase B-raf isoform 1 | NP_004324.2:p.Val600Asp | V (Val) > D (Asp) | Missense Variant |
BRAF transcript variant 1 |
NM_004333.6:c.1799_1800de… NM_004333.6:c.1799_1800delinsAC |
V [GTG] > D [GAC] | Coding Sequence Variant |
serine/threonine-protein kinase B-raf isoform 1 | NP_004324.2:p.Val600Asp | V (Val) > D (Asp) | Missense Variant |
BRAF transcript variant 1 |
NM_004333.6:c.1799_1800de… NM_004333.6:c.1799_1800delinsAA |
V [GTG] > E [GAA] | Coding Sequence Variant |
serine/threonine-protein kinase B-raf isoform 1 | NP_004324.2:p.Val600Glu | V (Val) > E (Glu) | Missense Variant |
BRAF transcript variant 2 |
NM_001354609.2:c.1799_180… NM_001354609.2:c.1799_1800delinsAT |
V [GTG] > D [GAT] | Coding Sequence Variant |
serine/threonine-protein kinase B-raf isoform 2 | NP_001341538.1:p.Val600Asp | V (Val) > D (Asp) | Missense Variant |
BRAF transcript variant 2 |
NM_001354609.2:c.1799_180… NM_001354609.2:c.1799_1800delinsAC |
V [GTG] > D [GAC] | Coding Sequence Variant |
serine/threonine-protein kinase B-raf isoform 2 | NP_001341538.1:p.Val600Asp | V (Val) > D (Asp) | Missense Variant |
BRAF transcript variant 2 |
NM_001354609.2:c.1799_180… NM_001354609.2:c.1799_1800delinsAA |
V [GTG] > E [GAA] | Coding Sequence Variant |
serine/threonine-protein kinase B-raf isoform 2 | NP_001341538.1:p.Val600Glu | V (Val) > E (Glu) | Missense Variant |
BRAF transcript variant 4 |
NM_001374244.1:c.1919_192… NM_001374244.1:c.1919_1920delinsAT |
V [GTG] > D [GAT] | Coding Sequence Variant |
serine/threonine-protein kinase B-raf isoform 3 | NP_001361173.1:p.Val640Asp | V (Val) > D (Asp) | Missense Variant |
BRAF transcript variant 4 |
NM_001374244.1:c.1919_192… NM_001374244.1:c.1919_1920delinsAC |
V [GTG] > D [GAC] | Coding Sequence Variant |
serine/threonine-protein kinase B-raf isoform 3 | NP_001361173.1:p.Val640Asp | V (Val) > D (Asp) | Missense Variant |
BRAF transcript variant 4 |
NM_001374244.1:c.1919_192… NM_001374244.1:c.1919_1920delinsAA |
V [GTG] > E [GAA] | Coding Sequence Variant |
serine/threonine-protein kinase B-raf isoform 3 | NP_001361173.1:p.Val640Glu | V (Val) > E (Glu) | Missense Variant |
BRAF transcript variant 5 |
NM_001374258.1:c.1919_192… NM_001374258.1:c.1919_1920delinsAT |
V [GTG] > D [GAT] | Coding Sequence Variant |
serine/threonine-protein kinase B-raf isoform 4 | NP_001361187.1:p.Val640Asp | V (Val) > D (Asp) | Missense Variant |
BRAF transcript variant 5 |
NM_001374258.1:c.1919_192… NM_001374258.1:c.1919_1920delinsAC |
V [GTG] > D [GAC] | Coding Sequence Variant |
serine/threonine-protein kinase B-raf isoform 4 | NP_001361187.1:p.Val640Asp | V (Val) > D (Asp) | Missense Variant |
BRAF transcript variant 5 |
NM_001374258.1:c.1919_192… NM_001374258.1:c.1919_1920delinsAA |
V [GTG] > E [GAA] | Coding Sequence Variant |
serine/threonine-protein kinase B-raf isoform 4 | NP_001361187.1:p.Val640Glu | V (Val) > E (Glu) | Missense Variant |
BRAF transcript variant 11 |
NM_001378472.1:c.1643_164… NM_001378472.1:c.1643_1644delinsAT |
V [GTG] > D [GAT] | Coding Sequence Variant |
serine/threonine-protein kinase B-raf isoform 10 | NP_001365401.1:p.Val548Asp | V (Val) > D (Asp) | Missense Variant |
BRAF transcript variant 11 |
NM_001378472.1:c.1643_164… NM_001378472.1:c.1643_1644delinsAC |
V [GTG] > D [GAC] | Coding Sequence Variant |
serine/threonine-protein kinase B-raf isoform 10 | NP_001365401.1:p.Val548Asp | V (Val) > D (Asp) | Missense Variant |
BRAF transcript variant 11 |
NM_001378472.1:c.1643_164… NM_001378472.1:c.1643_1644delinsAA |
V [GTG] > E [GAA] | Coding Sequence Variant |
serine/threonine-protein kinase B-raf isoform 10 | NP_001365401.1:p.Val548Glu | V (Val) > E (Glu) | Missense Variant |
BRAF transcript variant 6 |
NM_001378467.1:c.1808_180… NM_001378467.1:c.1808_1809delinsAT |
V [GTG] > D [GAT] | Coding Sequence Variant |
serine/threonine-protein kinase B-raf isoform 5 | NP_001365396.1:p.Val603Asp | V (Val) > D (Asp) | Missense Variant |
BRAF transcript variant 6 |
NM_001378467.1:c.1808_180… NM_001378467.1:c.1808_1809delinsAC |
V [GTG] > D [GAC] | Coding Sequence Variant |
serine/threonine-protein kinase B-raf isoform 5 | NP_001365396.1:p.Val603Asp | V (Val) > D (Asp) | Missense Variant |
BRAF transcript variant 6 |
NM_001378467.1:c.1808_180… NM_001378467.1:c.1808_1809delinsAA |
V [GTG] > E [GAA] | Coding Sequence Variant |
serine/threonine-protein kinase B-raf isoform 5 | NP_001365396.1:p.Val603Glu | V (Val) > E (Glu) | Missense Variant |
BRAF transcript variant 8 |
NM_001378469.1:c.1733_173… NM_001378469.1:c.1733_1734delinsAT |
V [GTG] > D [GAT] | Coding Sequence Variant |
serine/threonine-protein kinase B-raf isoform 7 | NP_001365398.1:p.Val578Asp | V (Val) > D (Asp) | Missense Variant |
BRAF transcript variant 8 |
NM_001378469.1:c.1733_173… NM_001378469.1:c.1733_1734delinsAC |
V [GTG] > D [GAC] | Coding Sequence Variant |
serine/threonine-protein kinase B-raf isoform 7 | NP_001365398.1:p.Val578Asp | V (Val) > D (Asp) | Missense Variant |
BRAF transcript variant 8 |
NM_001378469.1:c.1733_173… NM_001378469.1:c.1733_1734delinsAA |
V [GTG] > E [GAA] | Coding Sequence Variant |
serine/threonine-protein kinase B-raf isoform 7 | NP_001365398.1:p.Val578Glu | V (Val) > E (Glu) | Missense Variant |
BRAF transcript variant 7 |
NM_001378468.1:c.1799_180… NM_001378468.1:c.1799_1800delinsAT |
V [GTG] > D [GAT] | Coding Sequence Variant |
serine/threonine-protein kinase B-raf isoform 6 | NP_001365397.1:p.Val600Asp | V (Val) > D (Asp) | Missense Variant |
BRAF transcript variant 7 |
NM_001378468.1:c.1799_180… NM_001378468.1:c.1799_1800delinsAC |
V [GTG] > D [GAC] | Coding Sequence Variant |
serine/threonine-protein kinase B-raf isoform 6 | NP_001365397.1:p.Val600Asp | V (Val) > D (Asp) | Missense Variant |
BRAF transcript variant 7 |
NM_001378468.1:c.1799_180… NM_001378468.1:c.1799_1800delinsAA |
V [GTG] > E [GAA] | Coding Sequence Variant |
serine/threonine-protein kinase B-raf isoform 6 | NP_001365397.1:p.Val600Glu | V (Val) > E (Glu) | Missense Variant |
BRAF transcript variant 9 |
NM_001378470.1:c.1697_169… NM_001378470.1:c.1697_1698delinsAT |
V [GTG] > D [GAT] | Coding Sequence Variant |
serine/threonine-protein kinase B-raf isoform 8 | NP_001365399.1:p.Val566Asp | V (Val) > D (Asp) | Missense Variant |
BRAF transcript variant 9 |
NM_001378470.1:c.1697_169… NM_001378470.1:c.1697_1698delinsAC |
V [GTG] > D [GAC] | Coding Sequence Variant |
serine/threonine-protein kinase B-raf isoform 8 | NP_001365399.1:p.Val566Asp | V (Val) > D (Asp) | Missense Variant |
BRAF transcript variant 9 |
NM_001378470.1:c.1697_169… NM_001378470.1:c.1697_1698delinsAA |
V [GTG] > E [GAA] | Coding Sequence Variant |
serine/threonine-protein kinase B-raf isoform 8 | NP_001365399.1:p.Val566Glu | V (Val) > E (Glu) | Missense Variant |
BRAF transcript variant 14 |
NM_001378475.1:c.1535_153… NM_001378475.1:c.1535_1536delinsAT |
V [GTG] > D [GAT] | Coding Sequence Variant |
serine/threonine-protein kinase B-raf isoform 13 | NP_001365404.1:p.Val512Asp | V (Val) > D (Asp) | Missense Variant |
BRAF transcript variant 14 |
NM_001378475.1:c.1535_153… NM_001378475.1:c.1535_1536delinsAC |
V [GTG] > D [GAC] | Coding Sequence Variant |
serine/threonine-protein kinase B-raf isoform 13 | NP_001365404.1:p.Val512Asp | V (Val) > D (Asp) | Missense Variant |
BRAF transcript variant 14 |
NM_001378475.1:c.1535_153… NM_001378475.1:c.1535_1536delinsAA |
V [GTG] > E [GAA] | Coding Sequence Variant |
serine/threonine-protein kinase B-raf isoform 13 | NP_001365404.1:p.Val512Glu | V (Val) > E (Glu) | Missense Variant |
BRAF transcript variant 10 |
NM_001378471.1:c.1688_168… NM_001378471.1:c.1688_1689delinsAT |
V [GTG] > D [GAT] | Coding Sequence Variant |
serine/threonine-protein kinase B-raf isoform 9 | NP_001365400.1:p.Val563Asp | V (Val) > D (Asp) | Missense Variant |
BRAF transcript variant 10 |
NM_001378471.1:c.1688_168… NM_001378471.1:c.1688_1689delinsAC |
V [GTG] > D [GAC] | Coding Sequence Variant |
serine/threonine-protein kinase B-raf isoform 9 | NP_001365400.1:p.Val563Asp | V (Val) > D (Asp) | Missense Variant |
BRAF transcript variant 10 |
NM_001378471.1:c.1688_168… NM_001378471.1:c.1688_1689delinsAA |
V [GTG] > E [GAA] | Coding Sequence Variant |
serine/threonine-protein kinase B-raf isoform 9 | NP_001365400.1:p.Val563Glu | V (Val) > E (Glu) | Missense Variant |
BRAF transcript variant 12 |
NM_001378473.1:c.1643_164… NM_001378473.1:c.1643_1644delinsAT |
V [GTG] > D [GAT] | Coding Sequence Variant |
serine/threonine-protein kinase B-raf isoform 11 | NP_001365402.1:p.Val548Asp | V (Val) > D (Asp) | Missense Variant |
BRAF transcript variant 12 |
NM_001378473.1:c.1643_164… NM_001378473.1:c.1643_1644delinsAC |
V [GTG] > D [GAC] | Coding Sequence Variant |
serine/threonine-protein kinase B-raf isoform 11 | NP_001365402.1:p.Val548Asp | V (Val) > D (Asp) | Missense Variant |
BRAF transcript variant 12 |
NM_001378473.1:c.1643_164… NM_001378473.1:c.1643_1644delinsAA |
V [GTG] > E [GAA] | Coding Sequence Variant |
serine/threonine-protein kinase B-raf isoform 11 | NP_001365402.1:p.Val548Glu | V (Val) > E (Glu) | Missense Variant |
BRAF transcript variant 13 |
NM_001378474.1:c.1799_180… NM_001378474.1:c.1799_1800delinsAT |
V [GTG] > D [GAT] | Coding Sequence Variant |
serine/threonine-protein kinase B-raf isoform 12 | NP_001365403.1:p.Val600Asp | V (Val) > D (Asp) | Missense Variant |
BRAF transcript variant 13 |
NM_001378474.1:c.1799_180… NM_001378474.1:c.1799_1800delinsAC |
V [GTG] > D [GAC] | Coding Sequence Variant |
serine/threonine-protein kinase B-raf isoform 12 | NP_001365403.1:p.Val600Asp | V (Val) > D (Asp) | Missense Variant |
BRAF transcript variant 13 |
NM_001378474.1:c.1799_180… NM_001378474.1:c.1799_1800delinsAA |
V [GTG] > E [GAA] | Coding Sequence Variant |
serine/threonine-protein kinase B-raf isoform 12 | NP_001365403.1:p.Val600Glu | V (Val) > E (Glu) | Missense Variant |
BRAF transcript variant X4 |
XM_047420768.1:c.1815-391… XM_047420768.1:c.1815-3918_1815-3917delinsAT |
N/A | Intron Variant |
BRAF transcript variant X5 |
XM_047420769.1:c.1695-391… XM_047420769.1:c.1695-3918_1695-3917delinsAT |
N/A | Intron Variant |
BRAF transcript variant X1 |
XM_017012559.2:c.1919_192… XM_017012559.2:c.1919_1920delinsAT |
V [GTG] > D [GAT] | Coding Sequence Variant |
serine/threonine-protein kinase B-raf isoform X1 | XP_016868048.1:p.Val640Asp | V (Val) > D (Asp) | Missense Variant |
BRAF transcript variant X1 |
XM_017012559.2:c.1919_192… XM_017012559.2:c.1919_1920delinsAC |
V [GTG] > D [GAC] | Coding Sequence Variant |
serine/threonine-protein kinase B-raf isoform X1 | XP_016868048.1:p.Val640Asp | V (Val) > D (Asp) | Missense Variant |
BRAF transcript variant X1 |
XM_017012559.2:c.1919_192… XM_017012559.2:c.1919_1920delinsAA |
V [GTG] > E [GAA] | Coding Sequence Variant |
serine/threonine-protein kinase B-raf isoform X1 | XP_016868048.1:p.Val640Glu | V (Val) > E (Glu) | Missense Variant |
BRAF transcript variant X2 |
XM_047420766.1:c.1763_176… XM_047420766.1:c.1763_1764delinsAT |
V [GTG] > D [GAT] | Coding Sequence Variant |
serine/threonine-protein kinase B-raf isoform X2 | XP_047276722.1:p.Val588Asp | V (Val) > D (Asp) | Missense Variant |
BRAF transcript variant X2 |
XM_047420766.1:c.1763_176… XM_047420766.1:c.1763_1764delinsAC |
V [GTG] > D [GAC] | Coding Sequence Variant |
serine/threonine-protein kinase B-raf isoform X2 | XP_047276722.1:p.Val588Asp | V (Val) > D (Asp) | Missense Variant |
BRAF transcript variant X2 |
XM_047420766.1:c.1763_176… XM_047420766.1:c.1763_1764delinsAA |
V [GTG] > E [GAA] | Coding Sequence Variant |
serine/threonine-protein kinase B-raf isoform X2 | XP_047276722.1:p.Val588Glu | V (Val) > E (Glu) | Missense Variant |
BRAF transcript variant X3 |
XM_047420767.1:c.1919_192… XM_047420767.1:c.1919_1920delinsAT |
V [GTG] > D [GAT] | Coding Sequence Variant |
serine/threonine-protein kinase B-raf isoform X3 | XP_047276723.1:p.Val640Asp | V (Val) > D (Asp) | Missense Variant |
BRAF transcript variant X3 |
XM_047420767.1:c.1919_192… XM_047420767.1:c.1919_1920delinsAC |
V [GTG] > D [GAC] | Coding Sequence Variant |
serine/threonine-protein kinase B-raf isoform X3 | XP_047276723.1:p.Val640Asp | V (Val) > D (Asp) | Missense Variant |
BRAF transcript variant X3 |
XM_047420767.1:c.1919_192… XM_047420767.1:c.1919_1920delinsAA |
V [GTG] > E [GAA] | Coding Sequence Variant |
serine/threonine-protein kinase B-raf isoform X3 | XP_047276723.1:p.Val640Glu | V (Val) > E (Glu) | Missense Variant |
BRAF transcript variant X6 |
XM_047420770.1:c.1085_108… XM_047420770.1:c.1085_1086delinsAT |
V [GTG] > D [GAT] | Coding Sequence Variant |
serine/threonine-protein kinase B-raf isoform X6 | XP_047276726.1:p.Val362Asp | V (Val) > D (Asp) | Missense Variant |
BRAF transcript variant X6 |
XM_047420770.1:c.1085_108… XM_047420770.1:c.1085_1086delinsAC |
V [GTG] > D [GAC] | Coding Sequence Variant |
serine/threonine-protein kinase B-raf isoform X6 | XP_047276726.1:p.Val362Asp | V (Val) > D (Asp) | Missense Variant |
BRAF transcript variant X6 |
XM_047420770.1:c.1085_108… XM_047420770.1:c.1085_1086delinsAA |
V [GTG] > E [GAA] | Coding Sequence Variant |
serine/threonine-protein kinase B-raf isoform X6 | XP_047276726.1:p.Val362Glu | V (Val) > E (Glu) | Missense Variant |
Clinical Significance tab shows a list of clinical significance entries from ClinVar associated with the variation, per allele. Click on the RCV accession (i.e. RCV000001615.2) or Allele ID (i.e. 12274) to access full ClinVar report.
ClinVar Accession | Disease Names | Clinical Significance |
---|---|---|
RCV000423512.1 | Melanoma | Pathogenic |
ClinVar Accession | Disease Names | Clinical Significance |
---|---|---|
RCV003222500.1 | Melanoma | Uncertain-Significance |
ClinVar Accession | Disease Names | Clinical Significance |
---|---|---|
RCV000424781.1 | Colonic neoplasm | Likely-Pathogenic |
RCV000442563.1 | Melanoma | Likely-Pathogenic |
Aliases tab displays HGVS names representing the variant placements and allele changes on genomic, transcript and protein sequences, per allele. HGVS name is an expression for reporting sequence accession and version, sequence type, position, and allele change. The column "Note" can have two values: "diff" means that there is a difference between the reference allele (variation interval) at the placement reported in HGVS name and the reference alleles reported in other HGVS names, and "rev" means that the sequence of this variation interval at the placement reported in HGVS name is in reverse orientation to the sequence(s) of this variation in other HGVS names not labeled as "rev".
Placement | CA= | AT | GT | TT |
---|---|---|---|---|
GRCh38.p14 chr 7 | NC_000007.14:g.140753335_140753336= | NC_000007.14:g.140753335_140753336delinsAT | NC_000007.14:g.140753335_140753336delinsGT | NC_000007.14:g.140753335_140753336delinsTT |
GRCh37.p13 chr 7 | NC_000007.13:g.140453135_140453136= | NC_000007.13:g.140453135_140453136delinsAT | NC_000007.13:g.140453135_140453136delinsGT | NC_000007.13:g.140453135_140453136delinsTT |
BRAF RefSeqGene (LRG_299) | NG_007873.3:g.176429_176430= | NG_007873.3:g.176429_176430delinsAT | NG_007873.3:g.176429_176430delinsAC | NG_007873.3:g.176429_176430delinsAA |
BRAF transcript variant 1 | NM_004333.6:c.1799_1800= | NM_004333.6:c.1799_1800delinsAT | NM_004333.6:c.1799_1800delinsAC | NM_004333.6:c.1799_1800delinsAA |
BRAF transcript variant 1 | NM_004333.5:c.1799_1800= | NM_004333.5:c.1799_1800delinsAT | NM_004333.5:c.1799_1800delinsAC | NM_004333.5:c.1799_1800delinsAA |
BRAF transcript | NM_004333.4:c.1799_1800= | NM_004333.4:c.1799_1800delinsAT | NM_004333.4:c.1799_1800delinsAC | NM_004333.4:c.1799_1800delinsAA |
BRAF transcript variant 2 | NM_001354609.2:c.1799_1800= | NM_001354609.2:c.1799_1800delinsAT | NM_001354609.2:c.1799_1800delinsAC | NM_001354609.2:c.1799_1800delinsAA |
BRAF transcript variant 2 | NM_001354609.1:c.1799_1800= | NM_001354609.1:c.1799_1800delinsAT | NM_001354609.1:c.1799_1800delinsAC | NM_001354609.1:c.1799_1800delinsAA |
BRAF transcript variant 5 | NM_001374258.1:c.1919_1920= | NM_001374258.1:c.1919_1920delinsAT | NM_001374258.1:c.1919_1920delinsAC | NM_001374258.1:c.1919_1920delinsAA |
BRAF transcript variant 6 | NM_001378467.1:c.1808_1809= | NM_001378467.1:c.1808_1809delinsAT | NM_001378467.1:c.1808_1809delinsAC | NM_001378467.1:c.1808_1809delinsAA |
BRAF transcript variant 9 | NM_001378470.1:c.1697_1698= | NM_001378470.1:c.1697_1698delinsAT | NM_001378470.1:c.1697_1698delinsAC | NM_001378470.1:c.1697_1698delinsAA |
BRAF transcript variant 10 | NM_001378471.1:c.1688_1689= | NM_001378471.1:c.1688_1689delinsAT | NM_001378471.1:c.1688_1689delinsAC | NM_001378471.1:c.1688_1689delinsAA |
BRAF transcript variant 7 | NM_001378468.1:c.1799_1800= | NM_001378468.1:c.1799_1800delinsAT | NM_001378468.1:c.1799_1800delinsAC | NM_001378468.1:c.1799_1800delinsAA |
BRAF transcript variant 14 | NM_001378475.1:c.1535_1536= | NM_001378475.1:c.1535_1536delinsAT | NM_001378475.1:c.1535_1536delinsAC | NM_001378475.1:c.1535_1536delinsAA |
BRAF transcript variant 11 | NM_001378472.1:c.1643_1644= | NM_001378472.1:c.1643_1644delinsAT | NM_001378472.1:c.1643_1644delinsAC | NM_001378472.1:c.1643_1644delinsAA |
BRAF transcript variant 4 | NM_001374244.1:c.1919_1920= | NM_001374244.1:c.1919_1920delinsAT | NM_001374244.1:c.1919_1920delinsAC | NM_001374244.1:c.1919_1920delinsAA |
BRAF transcript variant 8 | NM_001378469.1:c.1733_1734= | NM_001378469.1:c.1733_1734delinsAT | NM_001378469.1:c.1733_1734delinsAC | NM_001378469.1:c.1733_1734delinsAA |
BRAF transcript variant 12 | NM_001378473.1:c.1643_1644= | NM_001378473.1:c.1643_1644delinsAT | NM_001378473.1:c.1643_1644delinsAC | NM_001378473.1:c.1643_1644delinsAA |
BRAF transcript variant X1 | XM_017012559.2:c.1919_1920= | XM_017012559.2:c.1919_1920delinsAT | XM_017012559.2:c.1919_1920delinsAC | XM_017012559.2:c.1919_1920delinsAA |
BRAF transcript variant X2 | XM_017012559.1:c.1919_1920= | XM_017012559.1:c.1919_1920delinsAT | XM_017012559.1:c.1919_1920delinsAC | XM_017012559.1:c.1919_1920delinsAA |
BRAF transcript variant 3 | NR_148928.2:n.2898_2899= | NR_148928.2:n.2898_2899delinsAT | NR_148928.2:n.2898_2899delinsAC | NR_148928.2:n.2898_2899delinsAA |
BRAF transcript variant X2 | XM_047420766.1:c.1763_1764= | XM_047420766.1:c.1763_1764delinsAT | XM_047420766.1:c.1763_1764delinsAC | XM_047420766.1:c.1763_1764delinsAA |
BRAF transcript variant X6 | XM_047420770.1:c.1085_1086= | XM_047420770.1:c.1085_1086delinsAT | XM_047420770.1:c.1085_1086delinsAC | XM_047420770.1:c.1085_1086delinsAA |
BRAF transcript variant 3 | NR_148928.1:n.2897_2898= | NR_148928.1:n.2897_2898delinsAT | NR_148928.1:n.2897_2898delinsAC | NR_148928.1:n.2897_2898delinsAA |
BRAF transcript variant 13 | NM_001378474.1:c.1799_1800= | NM_001378474.1:c.1799_1800delinsAT | NM_001378474.1:c.1799_1800delinsAC | NM_001378474.1:c.1799_1800delinsAA |
BRAF transcript variant X3 | XM_047420767.1:c.1919_1920= | XM_047420767.1:c.1919_1920delinsAT | XM_047420767.1:c.1919_1920delinsAC | XM_047420767.1:c.1919_1920delinsAA |
serine/threonine-protein kinase B-raf isoform 1 | NP_004324.2:p.Val600= | NP_004324.2:p.Val600Asp | NP_004324.2:p.Val600Asp | NP_004324.2:p.Val600Glu |
serine/threonine-protein kinase B-raf isoform 2 | NP_001341538.1:p.Val600= | NP_001341538.1:p.Val600Asp | NP_001341538.1:p.Val600Asp | NP_001341538.1:p.Val600Glu |
serine/threonine-protein kinase B-raf isoform 4 | NP_001361187.1:p.Val640= | NP_001361187.1:p.Val640Asp | NP_001361187.1:p.Val640Asp | NP_001361187.1:p.Val640Glu |
serine/threonine-protein kinase B-raf isoform 5 | NP_001365396.1:p.Val603= | NP_001365396.1:p.Val603Asp | NP_001365396.1:p.Val603Asp | NP_001365396.1:p.Val603Glu |
serine/threonine-protein kinase B-raf isoform 8 | NP_001365399.1:p.Val566= | NP_001365399.1:p.Val566Asp | NP_001365399.1:p.Val566Asp | NP_001365399.1:p.Val566Glu |
serine/threonine-protein kinase B-raf isoform 9 | NP_001365400.1:p.Val563= | NP_001365400.1:p.Val563Asp | NP_001365400.1:p.Val563Asp | NP_001365400.1:p.Val563Glu |
serine/threonine-protein kinase B-raf isoform 6 | NP_001365397.1:p.Val600= | NP_001365397.1:p.Val600Asp | NP_001365397.1:p.Val600Asp | NP_001365397.1:p.Val600Glu |
serine/threonine-protein kinase B-raf isoform 13 | NP_001365404.1:p.Val512= | NP_001365404.1:p.Val512Asp | NP_001365404.1:p.Val512Asp | NP_001365404.1:p.Val512Glu |
serine/threonine-protein kinase B-raf isoform 10 | NP_001365401.1:p.Val548= | NP_001365401.1:p.Val548Asp | NP_001365401.1:p.Val548Asp | NP_001365401.1:p.Val548Glu |
serine/threonine-protein kinase B-raf isoform 3 | NP_001361173.1:p.Val640= | NP_001361173.1:p.Val640Asp | NP_001361173.1:p.Val640Asp | NP_001361173.1:p.Val640Glu |
serine/threonine-protein kinase B-raf isoform 7 | NP_001365398.1:p.Val578= | NP_001365398.1:p.Val578Asp | NP_001365398.1:p.Val578Asp | NP_001365398.1:p.Val578Glu |
serine/threonine-protein kinase B-raf isoform 11 | NP_001365402.1:p.Val548= | NP_001365402.1:p.Val548Asp | NP_001365402.1:p.Val548Asp | NP_001365402.1:p.Val548Glu |
serine/threonine-protein kinase B-raf isoform X1 | XP_016868048.1:p.Val640= | XP_016868048.1:p.Val640Asp | XP_016868048.1:p.Val640Asp | XP_016868048.1:p.Val640Glu |
serine/threonine-protein kinase B-raf isoform X2 | XP_047276722.1:p.Val588= | XP_047276722.1:p.Val588Asp | XP_047276722.1:p.Val588Asp | XP_047276722.1:p.Val588Glu |
serine/threonine-protein kinase B-raf isoform X6 | XP_047276726.1:p.Val362= | XP_047276726.1:p.Val362Asp | XP_047276726.1:p.Val362Asp | XP_047276726.1:p.Val362Glu |
serine/threonine-protein kinase B-raf isoform 12 | NP_001365403.1:p.Val600= | NP_001365403.1:p.Val600Asp | NP_001365403.1:p.Val600Asp | NP_001365403.1:p.Val600Glu |
serine/threonine-protein kinase B-raf isoform X3 | XP_047276723.1:p.Val640= | XP_047276723.1:p.Val640Asp | XP_047276723.1:p.Val640Asp | XP_047276723.1:p.Val640Glu |
BRAF transcript variant X4 | XM_047420768.1:c.1815-3917= | XM_047420768.1:c.1815-3918_1815-3917delinsAT | XM_047420768.1:c.1815-3918_1815-3917delinsAC | XM_047420768.1:c.1815-3918_1815-3917delinsAA |
BRAF transcript variant X5 | XM_047420769.1:c.1695-3917= | XM_047420769.1:c.1695-3918_1695-3917delinsAT | XM_047420769.1:c.1695-3918_1695-3917delinsAC | XM_047420769.1:c.1695-3918_1695-3917delinsAA |
Submissions tab displays variations originally submitted to dbSNP, now supporting this RefSNP cluster (rs). We display Submitter handle, Submission identifier, Date and Build number, when the submission appeared for the first time. Direct submissions to dbSNP have Submission ID in the form of an ss-prefixed number (ss#). Other supporting variations are listed in the table without ss#.
No | Submitter | Submission ID | Date (Build) |
---|---|---|---|
1 | DF-BWCC | ss275515232 | Nov 22, 2010 (133) |
2 | CLINVAR | ss2137498009 | Apr 13, 2017 (150) |
3 | CLINVAR | ss2137504408 | Apr 18, 2017 (150) |
4 | CSS-BFX | ss8442109017 | Nov 03, 2024 (157) |
5 | CSS-BFX | ss8442109018 | Nov 03, 2024 (157) |
6 | CSS-BFX | ss8442109019 | Nov 03, 2024 (157) |
7 | ClinVar | RCV000423512.1 | Oct 12, 2018 (152) |
8 | ClinVar | RCV000424781.1 | Oct 12, 2018 (152) |
9 | ClinVar | RCV000442563.1 | Oct 12, 2018 (152) |
10 | ClinVar | RCV003222500.1 | Nov 03, 2024 (157) |
History tab displays RefSNPs (Associated ID) from previous builds (Build) that now support the current RefSNP, and the dates, when the history was updated for each Associated ID (History Updated).
Submission IDs | Observation SPDI | Canonical SPDI | Source RSIDs |
---|---|---|---|
ss8442109017 | NC_000007.13:140453134:CA:AT | NC_000007.14:140753334:CA:AT | (self) |
RCV000423512.1, ss275515232 | NC_000007.14:140753334:CA:AT | NC_000007.14:140753334:CA:AT | (self) |
ss8442109018 | NC_000007.13:140453134:CA:GT | NC_000007.14:140753334:CA:GT | (self) |
RCV003222500.1 | NC_000007.14:140753334:CA:GT | NC_000007.14:140753334:CA:GT | |
ss8442109019 | NC_000007.13:140453134:CA:TT | NC_000007.14:140753334:CA:TT | (self) |
RCV000424781.1, RCV000442563.1, ss2137498009, ss2137504408 | NC_000007.14:140753334:CA:TT | NC_000007.14:140753334:CA:TT | (self) |
Publications tab displays PubMed articles citing the variation as a listing of PMID, Title, Author, Year, Journal, ordered by Year, descending.
PMID | Title | Author | Year | Journal |
---|---|---|---|---|
12068308 | Mutations of the BRAF gene in human cancer. | Davies H et al. | 2002 | Nature |
14679157 | Determinants of BRAF mutations in primary melanomas. | Maldonado JL et al. | 2003 | Journal of the National Cancer Institute |
20551065 | RG7204 (PLX4032), a selective BRAFV600E inhibitor, displays potent antitumor activity in preclinical melanoma models. | Yang H et al. | 2010 | Cancer research |
20630094 | Incidence of the V600K mutation among melanoma patients with BRAF mutations, and potential therapeutic response to the specific BRAF inhibitor PLX4032. | Rubinstein JC et al. | 2010 | Journal of translational medicine |
20818844 | Inhibition of mutated, activated BRAF in metastatic melanoma. | Flaherty KT et al. | 2010 | The New England journal of medicine |
21639808 | Improved survival with vemurafenib in melanoma with BRAF V600E mutation. | Chapman PB et al. | 2011 | The New England journal of medicine |
22048237 | Phase II, open-label, randomized trial of the MEK1/2 inhibitor selumetinib as monotherapy versus temozolomide in patients with advanced melanoma. | Kirkwood JM et al. | 2012 | Clinical cancer research |
22281684 | Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR. | Prahallad A et al. | 2012 | Nature |
22356324 | Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib. | Sosman JA et al. | 2012 | The New England journal of medicine |
22608338 | Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial. | Falchook GS et al. | 2012 | Lancet (London, England) |
22663011 | Improved survival with MEK inhibition in BRAF-mutated melanoma. | Flaherty KT et al. | 2012 | The New England journal of medicine |
22735384 | Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial. | Hauschild A et al. | 2012 | Lancet (London, England) |
22805292 | Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial. | Falchook GS et al. | 2012 | The Lancet. Oncology |
22972589 | Clinical responses to selumetinib (AZD6244; ARRY-142886)-based combination therapy stratified by gene mutations in patients with metastatic melanoma. | Patel SP et al. | 2013 | Cancer |
23020132 | Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations. | Flaherty KT et al. | 2012 | The New England journal of medicine |
23031422 | Overwhelming response to Dabrafenib in a patient with double BRAF mutation (V600E; V600M) metastatic malignant melanoma. | Ponti G et al. | 2012 | Journal of hematology & oncology |
23317446 | Effect of dabrafenib on melanoma cell lines harbouring the BRAF(V600D/R) mutations. | Gentilcore G et al. | 2013 | BMC cancer |
23918947 | Phase II trial (BREAK-2) of the BRAF inhibitor dabrafenib (GSK2118436) in patients with metastatic melanoma. | Ascierto PA et al. | 2013 | Journal of clinical oncology |
25157968 | Prospective enterprise-level molecular genotyping of a cohort of cancer patients. | MacConaill LE et al. | 2014 | The Journal of molecular diagnostics |
The Flanks tab provides retrieving flanking sequences of a SNP on all molecules that have placements.
Genomic regions, transcripts, and products
Top▲
Help
NCBI Graphical Sequence Viewer display of the genomic region, transcripts and protein products for the reported RefSNP (rs).
Use the zoom option to view the nucleotides around the RefSNP and find other neighboring RefSNPs.
Visit Sequence Viewer for help with navigating inside the display and modifying the selection of displayed data tracks.
NCBI Graphical Sequence Viewer display of the genomic region, transcripts and protein products for the reported RefSNP (rs).
Use the zoom option to view the nucleotides around the RefSNP and find other neighboring RefSNPs.
Visit Sequence Viewer for help with navigating inside the display and modifying the selection of displayed data tracks.